טוען...
A matched comparison of eptifibatide plus rt-PA versus rt-PA alone in acute ischemic stroke
BACKGROUND: The Combined Approach to Lysis Utilizing Eptifibatide and rt-PA in Acute Ischemic Stroke-Enhanced Regimen (CLEAR-ER) trial found that IV rt-PA plus eptifibatide (combination arm) in acute ischemic stroke (AIS) was safe, and had a direction of effect that would justify a phase III trial....
שמור ב:
| Main Authors: | , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2014
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4035416/ https://ncbi.nlm.nih.gov/pubmed/24534128 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jstrokecerebrovasdis.2013.12.012 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|